Potential repurposing of the HDAC inhibitor valproic acid for patients with COVID-19
Bertram Pitt, Nadia R. Sutton, Zhong Wang, Sascha N. Goonewardena, Michael Holinstat
Topics & Concepts
Valproic AcidRepurposingHistone deacetylase inhibitorDrug repositioningPharmacologyHistone deacetylaseMedicineSerine proteaseImmune systemDrugImmunologyEpilepsyProteaseChemistryHistoneBiologyEnzymeBiochemistryGenePsychiatryEcologyPharmacological Effects and Toxicity StudiesHistone Deacetylase Inhibitors ResearchPharmacological Receptor Mechanisms and Effects